Jim Simons Oyster Point Pharma, Inc. Transaction History

Renaissance Technologies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$3.6 - $11.2 $15,480 - $48,160	4,300 Added 30.28%	18,500 $80,000
Q1 2022 May 13, 2022	SELL	$8.58 - $17.65 $90,090 - $185,324	-10,500 Reduced 42.51%	14,200 $165,000
Q4 2021 Feb 11, 2022	SELL	$10.17 - $18.96 $890,892 - $1.66 Million	-87,600 Reduced 78.01%	24,700 $451,000
Q3 2021 Nov 12, 2021	BUY	$11.67 - $18.07 $1.31 Million - $2.03 Million	112,300 New	112,300 $1.33 Million
Q1 2021 May 13, 2021	SELL	$17.92 - $25.86 $549,050 - $792,324	-30,639 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$18.13 - $25.18 $269,429 - $374,199	-14,861 Reduced 32.66%	30,639 $577,000
Q3 2020 Nov 13, 2020	BUY	$17.83 - $29.12 $192,563 - $314,496	10,800 Added 31.12%	45,500 $961,000
Q2 2020 Aug 13, 2020	BUY	$27.86 - $35.93 $966,742 - $1.25 Million	34,700 New	34,700 $1 Million

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.